Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0OIXMY
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
37217025 ADC-2
|
|||||
| Synonyms |
ADC-2
Click to Show/Hide
|
|||||
| Organization |
Zymeworks Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Structure |
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
TLR7/8 agonist 20h
|
Payload Info | ||||
| Therapeutic Target |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
|
Target Info | ||||
| Linker Name |
MT-VC-PABC
|
Linker Info | ||||
| Conjugate Type |
Site-specific conjugation via re-bridging.
|
|||||